Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.54 USD
−98.15 M USD
0.00 USD
31.96 M
About CARGO Therapeutics, Inc.
Sector
Industry
CEO
Gina Chapman
Website
Headquarters
San Carlos
Founded
2019
FIGI
BBG01D59LY25
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Carlos, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CRGX is 19.03 USD — it has decreased by −3.82% in the past 24 hours. Watch CARGO Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CARGO Therapeutics, Inc. stocks are traded under the ticker CRGX.
CRGX stock has risen by 0.09% compared to the previous week, the month change is a 12.45% rise, over the last year CARGO Therapeutics, Inc. has showed a 29.54% increase.
We've gathered analysts' opinions on CARGO Therapeutics, Inc. future price: according to them, CRGX price has a max estimate of 34.00 USD and a min estimate of 28.00 USD. Watch CRGX chart and read a more detailed CARGO Therapeutics, Inc. stock forecast: see what analysts think of CARGO Therapeutics, Inc. and suggest that you do with its stocks.
CRGX reached its all-time high on Mar 11, 2024 with the price of 33.92 USD, and its all-time low was 13.14 USD and was reached on Nov 13, 2023. View more price dynamics on CRGX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CRGX stock is 21.69% volatile and has beta coefficient of 1.92. Track CARGO Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is CARGO Therapeutics, Inc. there?
Today CARGO Therapeutics, Inc. has the market capitalization of 970.42 M, it has increased by 5.47% over the last week.
Yes, you can track CARGO Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
CARGO Therapeutics, Inc. is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
CRGX earnings for the last quarter are −0.88 USD per share, whereas the estimation was −1.11 USD resulting in a 20.62% surprise. The estimated earnings for the next quarter are −1.00 USD per share. See more details about CARGO Therapeutics, Inc. earnings.
CARGO Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
CRGX net income for the last quarter is −41.91 M USD, while the quarter before that showed −44.35 M USD of net income which accounts for 5.50% change. Track more CARGO Therapeutics, Inc. financial stats to get the full picture.
No, CRGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CRGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARGO Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARGO Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARGO Therapeutics, Inc. stock shows the neutral signal. See more of CARGO Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.